Phenolic compounds from <i>Origanum majorana</i> with biofilm-inhibitory activity against methicillin-resistant <i>Staphylococcus aureus</i> and <i>Escherichia coli</i> strains

The newly discovered natural antibiofilm agents show promise as candidates for treating biofilm-associated infections and combating antibiotic-resistant bacteria.

Authors

Institutions

Publication Details

Journal
Pharmaceutical Biology
Published
2025-06-02
DOI
https://doi.org/10.1080/13880209.2025.2511805
Citations
4
Primary Topic
Bacterial biofilms and quorum sensing
Type
article
Field-Weighted Citation Impact
3.22
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phenolic compounds from Origanum majorana with biofilm-inhibitory activity against methicillin-resistant Staphylococcus aureus and Escherichia coli strains

Gabriella Spengler, Tasneem Abu Ghazal, Annamária Kincses, Judit Hohmann et al.
4 citations
Pharmaceutical Biology
Bacterial biofilms and quorum sensing
3.22
article

Phenolic compounds from Origanum majorana with biofilm-inhibitory activity against methicillin-resistant Staphylococcus aureus and Escherichia coli strains

Gabriella Spengler, Tasneem Abu Ghazal, Annamária Kincses, Judit Hohmann, Katalin Veres
article en
4 citations

Abstract

The newly discovered natural antibiofilm agents show promise as candidates for treating biofilm-associated infections and combating antibiotic-resistant bacteria.

Pharmaceutical BiologyVol. 63(1)
University of Szeged (HU)
Openalex Percentile: Top 8%
Bacterial biofilms and quorum sensing
3.22
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.